Login to Your Account

U.S. Patent Disclosures

Thursday, July 11, 2013
• Fibrocell Science Inc., of Exton, Pa., was issued a U.S. patent for Laviv (azficel-T), related to azficel-T fibroblast suspension, which is a treatment for moderate to severe nasolabial fold wrinkles in adults.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription